Juvenile Huntington’s Disease: Diagnostic and Treatment Considerations for the Psychiatrist

Current Psychiatry Reports

Volumn 19, Issue 2, 2017, Pages

  Quigley, Joanna ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Anxiety; Chorea; Depression; Juvenile Huntington s disease; Neurodegenerative; Neuropsychiatric; Rigidity

Indexed keywords

ADENINE; CYTOSINE; DEUTETRABENAZINE; GUANINE; HUNTINGTIN; TETRABENAZINE;

ACADEMIC ACHIEVEMENT; ADOLESCENT DISEASE; AGGRESSION; ANXIETY; CHILDHOOD DISEASE; COGNITIVE DEFECT; DELAYED DIAGNOSIS; DEPRESSION; DIAGNOSTIC TEST; DYSTONIA; EXECUTIVE FUNCTION; HUMAN; HUNTINGTON CHOREA; HUNTINGTON GENE; IMPULSIVENESS; JUVENILE HUNTINGTON DISEASE; MENTAL PERFORMANCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE RIGIDITY; OCCUPATIONAL THERAPY; ONSET AGE; PSYCHIATRIST; QUALITY OF LIFE; REHABILITATION CARE; REVIEW; SEIZURE; ADOLESCENT; BEHAVIOR; CHILD; COGNITION DISORDERS; EARLY INTERVENTION; HUNTINGTON DISEASE; MENTAL DISORDERS; PSYCHIATRY; PSYCHOLOGY;

ADOLESCENT; BEHAVIORAL SYMPTOMS; CHILD; COGNITION DISORDERS; DELAYED DIAGNOSIS; EARLY MEDICAL INTERVENTION; HUMANS; HUNTINGTON DISEASE; MENTAL DISORDERS; PSYCHIATRY; QUALITY OF LIFE;

EID: 85011920499     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-017-0759-9     Document Type: Review

References (25)

1. The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72(6):971–83.
2. Douglas I, Evans S, Rawlins MD, Smeeth L, Tabrizi SJ, Wexler NS. Juvenile Huntington’s disease: a population-based study using the General Practice Research Database. BMJ Open. 2013;3, e002085.
3. Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom H, et al. Seizures in juvenile Huntington’s disease: frequency and characterization in a multicenter cohort. Mov Disord. 2012;27(14):1797–800.
4. Letort D, Gonzalez-Alegre P. Huntington's disease in children. Handb Clin Neurol. 2013;113:1913–7.
5. Deng P, Torrest A, Pollock K, Dahlenburg H, Annett G, Nolta JA, et al. Clinical trial perspective for adult and juvenile Huntington’s disease using genetically-engineered mesenchymal stem cells. Neural REgen Res. 2016;11(5):702–5.
6. Quarrell O, O’Donovan KL, Bandmann O, Strong M. The prevalence of juvenile Huntington’s disease: a review of the literature and meta-analysis. PLos Curr. 2012;4:e4f8606b742ef3.
7. Faroud T, Gray J, Ivashina J, Conneally PM. Differences in duration of Huntington’s disease based on age at onset. J Neurol Neurosurg Psychiatry. 1999;66:52–6.
8. n repeat length is the sex of the affected parent. Human Mol Gen. 1993;2(10):1535–40.
9. Nicholas G, Devys D, Goldenberg A, Maltete D, Herve C, Hannequin D, Guyant-Marechal L. Juvenile Huntington disease in a 18-month-old boy revealed by global developmental dealy and reduced cerebellar volume. Am J Med Genet 2011;Part A 155:815-818.
10. Chuo YP, Hou PH, Chan CH, Lin CC, Liao YC. Juvenile Huntington’s disease presenting as difficult-to-treat seizure and the first episode of psychosis. Gen Hosp Psych. 2012;34:436. e9-436.e11.
11. Ribaï P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, Vidailhet M, Legout A, et al. Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 pateints. Arch Neurol. 2007;64:813–9.
12. th ed. Philadelphia: W.B. Saunders Co; 2007. p. 2488–2493.
13. Lai SC, Jung SM, Grattan-Smith P, Sugo E, Lin YW, Chen RS, et al. Neuronal intranuclear inclusion disease: two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia. Mov Disord. 2010;25(9):1274–9.
14. Robertson L, Santini H, O’Donovan KL. Squitieri F, Barker RA, Rakowicz M, Landwehrmeyer GB, Quarrell O. Current pharmacological management in juvenile Huntington’s disease. PLoS Curr 2012 Feb 6 [revised 2012 Mar 26];4:RRN1304.
15. Rasmussen A, Macias R, Ochoa A, Davila G, Alonso E. Huntington disease in children: genotype-phenotype correlation. Neuropediatrics. 2000;31:190–4.
16. Quarrell OW, Nance MA, Nopoulos P, Paulsen JS, Smith JA, Squitieri F. Managing juvenile Huntington’s disease. Neurodegner Dis Manag 2013 June 1;3(3):.doi10.2217/nmt.13.18.
17. di Biase L, Munhoz RP. Deep brain stimulation for the treatment of hyperkinetic movement disorders. Exp Rev Neurotherapeutics. 2016;16(9):1067–78. doi:10.1080/14737175.2016.1196139. Epub 2016 Jun 10.
18. Aylward EH. Change in MRI striatal volumes as a biomarker in preclinical Huntington’s disease. Brain Res Bull. 2007;72:152–8.
19. Fink KD, Deng P, Torrest A, Stewart H, Pollack K, Gruenloh W, et al. Developing stem cell therapies for juvenile and adult-onset Huntington’s disease. Regen Med. 2015;10(5):623–46. Review of research into the use of mesenchymal stem cells and BDNF in the treatment of Huntington’s disease.
20. Gonzalez-Alegre P, Afifi AK. Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature. J Child Neurol. 2006;21:223–9.
21. Reilmann R, Leavitt BR, Ross CA. Diagnostic criteria for Huntington's disease based on natural history. Mov Disord. 2014;29(11):1335–41.
22. Orth M, Handley OJ, Shwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB. Observing Huntington’s disease: the European Huntington’s Disease Registry. PloS Curr 2010 September 28 [revised 2011 April 13]; Published online 2011 April 13. doi:10.1371/currents.RRN1184
23. Huntington Study Group. Unified Huntington’s disease rating scale: reliability and consistency. Mov Disord. 1996;11(2):136–42.
24. Mestre TA et al. Rating scales for behavioral symptoms in Huntington’s disease: critique and recommendations. Movement Disorders 2016 doi:10.1002/mds.26675. Highlighted the limitations of existing rating scales considering the complexity of behavioral symptoms in Huntington’s disease
25. The Huntington Study Group. Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial. JAMA. 2016;316(1):40–50. Trial of a novel therapy for treatment of chorea.